Fentanyl Transdermal Patch and Fluvoxamine: Interaction Details
- Fluvoxamine
- LuvoxLuvox CR
- Fentanyl Transdermal Patch
- DuragesicAbstralSubsys +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Fluvoxamine interaction:
Fluvoxamine
- Luvox
- Luvox CR
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
What Happens When You Take Fentanyl Transdermal Patch With Fluvoxamine
What can happen when they are taken together (rated Major)
Increased fentaNYL exposure and an increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When fentaNYL, a , is given together with a CYP3A4 that also has activity, fentaNYL may rise, which can heighten or extend its adverse effects. If the combination cannot be avoided, a lower fentaNYL dosage should be considered until drug effects have stabilized, and patients should be checked often for and .1
FentaNYL is regarded as a proserotonergic synthetic of the piperidine class, and serotonin syndrome has been reported when it was coadministered with a serotonergic drug. Caution is therefore warranted when fentaNYL is combined with any serotonergic agent.
Where feasible, a serotonergic opioid (eg, fentaNYL) could be swapped for a non-serotonergic opioid (eg, morphine).3 Patients should be observed for signs of serotonin syndrome, which can be life-threatening.
Should it occur, the causative drugs should be stopped and supportive care, along with any other needed treatment, should be given.2 If the CYP3A4 inhibitor is later stopped, increasing the fentaNYL dosage may be considered until drug effects are stable, while watching for signs of opioid withdrawal.1
The Fentanyl Transdermal Patch and Fluvoxamine Interaction, Explained
Fluvoxamine (Luvox) is an antidepressant, and fentanyl patches (Duragesic) are used for strong, ongoing pain. Taken together, two things can happen. Fluvoxamine can slow down how your body breaks down fentanyl, so more of it may stay in your system. That could mean extra drowsiness or slowed breathing. Both drugs can also raise , which in rare cases leads to (agitation, sweating, shaking, fast heartbeat, fever).
This is based mostly on how the drugs work, not on many reported cases. Still, it is taken seriously. Please keep using both as prescribed and talk with your pharmacist or doctor. They can adjust your dose and watch you more closely.
Mechanism: Fluvoxamine inhibits (fentanyl is a CYP3A4 ), which may raise fentanyl exposure (/) and prolong or intensify adverse effects. Both agents are also , so there is risk of . Fentanyl is active itself, so increases rather than reduces effect.
- Evidence: theoretical; onset unspecified; severity major.
- Management: if is necessary, consider fentanyl dose reduction until stable effects are reached, and monitor frequently for and .
- Monitor for serotonin syndrome. If it occurs, discontinue the offending agents and give supportive care.
- Consider a non-serotonergic opioid (e.g., morphine) if possible.
- If fluvoxamine is stopped, fentanyl exposure may fall, so the dose may need to be increased, and watch for opioid withdrawal.
See the 6 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Fluvoxamine Interact
The likely mechanism
of -mediated of fentaNYL;
How to Manage the Fentanyl Transdermal Patch and Fluvoxamine Interaction
Your care team can manage this combination by tailoring your treatment.
- Keep taking both medicines as prescribed, and do not change or stop either one on your own.
- Your doctor may adjust your fentanyl dose and check on you more often, especially for sleepiness and slowed breathing.
- If possible, they may consider a different pain medicine that does not affect .
- Tell your pharmacist or doctor right away about unusual agitation, sweating, shaking, muscle stiffness, fever, or very heavy drowsiness or slow breathing.
- If fluvoxamine is ever stopped, let your team know, because your fentanyl dose may need to be adjusted again and they will watch for withdrawal symptoms.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Fluvoxamine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
3 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy
linked to fentaNYL given during an esophagogastroduodenoscopy was described in a 39-year-old woman who was also taking sertraline 100 mg daily as an outpatient. She first presented with hematemesis and had a history of alcoholic cirrhosis.
Before the esophagogastroduodenoscopy, an octreotide and pantoprazole drip was begun, and she received 2 doses of fentaNYL 50 micrograms and 2 doses of midazolam 1 mg. After the procedure she became somnolent and markedly rigid in all four extremities, and vecuronium and etomidate were administered for immediate intubation.
The rigidity worsened and was accompanied by diffuse diaphoresis, horizontal roving eye movements, and a fever of 105 degrees F. Because of the possibility of seizure activity, LORazepam 2 mg IV was given without improvement, and a propofol drip was started for ongoing during intubation.
A CPK of 2800 units/L and an ammonia level of 340 micromols/L pointed to . A CT scan of the brain excluded an acute intracranial process, and the neurology team diagnosed serotonin syndrome resulting from an interaction between fentaNYL and sertraline.
Propofol was continued for sedation, and supportive treatment consisted of a cooling blanket and cyproheptadine. After 3 days the patient's temperature and CPK level returned to normal, and she was later extubated without further complications.4
-
Report 2 · Study title
Serotonin syndrome precipitated by fentanyl during procedural sedation
after IV fentaNYL administration during surgical procedures was reported in 2 patients who were also taking (sertraline and escitalopram). The first patient was given IV fentaNYL (50 micrograms), midazolam (2 mg), and 2 doses of propofol (60 mg and 40 mg) at an outpatient surgery center before a carpal tunnel release.
After surgery she began shivering and grew increasingly agitated, and she was moved to the emergency department. On presentation she was combative, diaphoretic, confused, unable to follow commands, tachycardic, and hypertensive, with hyperreflexia and ankle clonus.
Creatinine kinase rose to 613 units/L on hospital day 2. The toxicology service treated her with escalating doses of , with no improvement.
She was then intubated and sedated with a continuous propofol infusion. After 2 days she was extubated, and by day 3 all symptoms had resolved and she was discharged home.
The second patient, a 59-year-old woman, was admitted for an omentectomy and received IV fentaNYL 250 micrograms, etomidate, vecuronium, morphine, and cephazolin. After extubation she became hypoxic and acidotic, was reintubated, and was transferred to the ICU.
On postoperative day 1 she was extubated, and she later became tachycardic and unable to follow commands. On examination she was agitated and diaphoretic, with patellar hyperreflexia and bilateral ankle clonus of 3 to 4 beats.
Laboratory evaluation showed a peak creatine kinase of 1161 units/L on postoperative day 2. She was treated with LORazepam and cyproheptadine, and symptoms resolved after 3 days.5
-
Report 3 · Study title
Serotonin toxicity caused by an interaction between fentanyl and paroxetine
A case of postoperative after fentaNYL use for general anesthesia and postoperative analgesia was reported in a 60-year-old woman who was also receiving PARoxetine. Her outpatient medications were limited to PARoxetine and thyroxine, for a history of depression and hypothyroidism.
She was admitted for extensive resection of a recurrent left chest wall myxofibrosarcoma and received propofol and 200 micrograms (mcg) of fentaNYL to induce anesthesia. She was also given a further 800 mcg of fentaNYL intraoperatively (intermittent 50 mcg boluses), followed by a fentaNYL infusion (100 to 200 mcg/hr) for postoperative and analgesia (2545 mcg of fentanyl received over 36 hours).
The infusion was continued for 36 hours after surgery, at which point neurological examination revealed intermittent agitation, bilateral hypertonia and hyperreflexia, and bilateral inducible ankle clonus. Symptoms were more severe in the lower limbs and on the right side of the body.
A CT scan of the brain was unremarkable, and all other findings, including a thyroid function test, were within normal limits except for elevated blood pressure (180/90 mmHg), which resolved spontaneously 24 hours after the procedure. fentaNYL was stopped, and 24 hours later neurological symptoms had improved markedly, with complete recovery by postoperative day 4. The patient was eventually discharged home without further complications.6
Fentanyl Transdermal Patch and Fluvoxamine: Common Questions
How serious is the Fentanyl Transdermal Patch and Fluvoxamine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl Transdermal Patch and Fluvoxamine interaction managed?
Your care team can manage this combination by tailoring your treatment. Keep taking both medicines as prescribed, and do not change or stop either one on your own. Your doctor may adjust your fentanyl dose and check on you more often, especially for sleepiness and slowed breathing. If possible, they may consider a different pain medicine that does not affect . Tell your pharmacist or doct… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Fentanyl Transdermal Patch and Fluvoxamine Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Fluvoxamine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (6)
- Product Information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection. Hospira Inc (per FDA), Lake Forest, IL, 2023. DailyMed
- Boyer EW & Shannon M: The serotonin syndrome. N Eng J Med 2005; 352(11):1112-1120. PubMed
- Rastogi R, Swarm RA, & Patel TA: Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 2011; 115(6):1291-1298. PubMed
- Alkhatib AA, Peterson KA, & Tuteja AK: Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy. Dig Dis Sci 2010; 55(1):215-216. PubMed
- Kirschner R & Donovan JW: Serotonin syndrome precipitated by fentanyl during procedural sedation. J Emerg Med 2010; 38(4):477-480. PubMed
- Rang ST, Field J, & Irving C: Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth 2008; 55(8):521-525. PubMed
Other Serious Interactions of Fentanyl Transdermal Patch and Fluvoxamine
Also serious with Fluvoxamine
- ColchicineContraindicated
- Linezolid InjectionContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
Also serious with Fentanyl Transdermal Patch
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Fluvoxamine
- Activated CharcoalMajor
- LithiumMajor
- CaffeineModerate
- Green TeaModerate
- Black PepperModerate
- GrapeModerate
- GinkgoModerate
- MelatoninModerate
- + 187 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.